Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
8th International Conference on Alzheimer's Disease
 and Related Disorders:   Gal Bitan

Updated 16 December 2002

Return to 8th International Conference Index

Biophysical Studies of the Initial Oligomerization Events in Amyloid b-Protein Assembly

Gal Bitan†, Aleksey Lomakin‡, Tomas T. Ding†, Marina D. Kirkitadze†, Peter T. Lansbury†, George B. Benedek‡, and David B. Teplow†

David Teplow (left) and
Gal Bitan (right)

View Gal Bitan's presentation

Abstract: Soluble oligomers of the amyloid b-protein (Ab) are neurotoxic and have been shown to cause neuronal dysfunction in the absence of fibril formation. In particular, oligomers of Ab(1-42) have been implicated as neurotoxic effectors involved in early stages of Alzheimer's disease (AD). Understanding the formation of Ab oligomers and their role in the pathogenesis of AD is thus of clinical importance. Biophysical characterization of small Ab oligomers has been difficult due to the metastable nature of these assemblies. However, through the use of a technique termed Photo-Induced Cross-linking of Unmodified Protein (PICUP), we recently were able to demonstrate that low molecular weight (LMW) Ab(1-40) exists as a mixture of small oligomers in rapid equilibrium. Here, PICUP, dynamic light scattering (DLS), atomic force microscopy (AFM), and circular dichroism (CD) have been used in combination to study the oligomerization of LMW Ab(1-40) and Ab(1-42). Although no ordered secondary structure is detectable at early assembly stages, oligomers of both alloforms form immediately following isolation of LMW Ab. LMW Ab(1-40) comprises monomer, dimer, trimer, and tetramer, in rapid equilibrium, whereas LMW Ab(1-42) forms larger assemblies in which hexamers appear to be the "unit cells." Systematic study of Ab alloforms ranging in length from 40-43 amino acids revealed a direct correlation between Ab length and the oligomer size distribution. The analytical strategy used here should be of value for the study of other abnormal, and normal, protein oligomerization processes.

†Center for Neurologic Diseases, Brigham and Women's Hospital, and Department of Neurology, Harvard Medical School, Boston, MA 02115; ‡Department of Physics, Center for Material Science and Engineering, and Materials Processing Center, Massachusetts Institute of Technology, Cambridge, MA 02139

View Gal Bitan's presentation
To hear the associated audio, click on the "Play Audio" button on each slide.





Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad